Unlock instant, AI-driven research and patent intelligence for your innovation.

Pregnane glycoside compounds and their application

A technology of pregnane glycosides and compounds, applied in the field of pregnane glycoside compounds

Active Publication Date: 2020-11-17
KUNMING UNIV OF SCI & TECH
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The pregnane glycoside compound provided by the present invention and its use as an immunosuppressive drug and an anti-inflammatory drug have not been reported yet

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pregnane glycoside compounds and their application
  • Pregnane glycoside compounds and their application
  • Pregnane glycoside compounds and their application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0019] Example 1: Preparation of Epigycoside B

[0020] Burmese Simao vine ( Epigynum cochinchinensis ) branches and leaves, and 5 kg of the obtained leaves were dried naturally in a dry and ventilated place, and then crushed into pieces with a powder machine; the Burmese Simao vine leaf fragments were immersed in 10 L of methanol solution with a volume concentration of 75% for extraction, each time for 12 hours, continuous Leach three times; collect and combine the extracts, use a rotary evaporator to concentrate and remove the liquid under reduced pressure, and obtain 500 g of extract; add 2 L of water to dissolve the extract, put it in a separatory funnel, and then add an equal volume of ethyl acetate for repeated extraction ; Repeatedly extracted until the ethyl acetate layer was almost colorless, collected and combined the ethyl acetate layer and evaporated to dryness to obtain 120 g of the crude extract extract; using a medium pressure chromatographic separation system,...

Embodiment 2

[0030] Embodiment 2: Immunosuppression detection test

[0031] (1) Preparation of spleen lymphocyte suspension

[0032]18-22g healthy BABL / c mice were sacrificed by removing the eyeballs for bloodletting and then sacrificing them by taking off the neck, soaking them in 75% alcohol for 3-5 minutes, taking them out and placing them in a sterile tray with the left side of the abdomen facing upwards. In the cabinet, use sterilized tweezers to pick up the fur in the middle of the abdomen, make an incision from the lower end, use another set of instruments to cut open the layers of the abdominal wall, use the third set of instruments to remove the spleen, remove fat and connective tissue, and put it in PBS (Phosphate buffered saline) to wash away the floating blood. Then move the spleen tissue to a plate filled with RPMI1640 incomplete culture medium, cut it into small pieces with scissors, use a sterile syringe core to gently grind the spleen in a 200-mesh stainless steel screen, ...

Embodiment 3

[0060] Embodiment 3: in vitro anti-inflammatory activity test

[0061] (1) Preparation of test-related reagents

[0062] Preparation of sample dilution working solution: The concentrated sample dilution solution was taken out from the -4°C refrigerator, thawed slowly at room temperature, and diluted with double distilled water at a ratio of 1:5 according to the amount required for the test.

[0063] Preparation of reagent dilution working solution: take the concentrated reagent solution out of the -4°C refrigerator, thaw slowly at room temperature, take part according to the required amount of the test, and dilute it with double distilled water at a ratio of 1:5.

[0064] Preparation of cell lysis working solution: The concentrated cell lysate was taken out from the -4°C refrigerator, thawed slowly at room temperature, and diluted with double distilled water at a ratio of 1:2 according to the amount required for the test.

[0065] Preparation of washing working solution: Take...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a pregnane glycoside compound and application thereof to preparation of an immunosuppressive drug and an anti-inflammatory drug. The compound is extracted and isolated from a plant of epigynum, and the structural formula of the compound is shown in the description, wherein, both R1 and R2 are selected from glycosyl groups; tests show that the compound provided by the invention is excellent in immunosuppression and anti-inflammatory effects; and the compound provides lead compounds for the development of immunosuppressants and anti-inflammatory agents, and facilitates the development and utilization of plant medicinal resources.

Description

technical field [0001] The invention relates to a pregnane glycoside compound and its application in the preparation of immunosuppressive drugs and anti-inflammatory drugs. Background technique [0002] Immunosuppressants provide effective therapeutic drugs for autoimmune diseases and rejection after organ transplantation in clinic, and are usually used to suppress rejection after organ transplantation, treat graft-versus-host disease after bone marrow transplantation, or treat Autoimmune diseases such as rheumatoid arthritis and Crohn's disease. Anti-inflammatory drugs are drugs used to treat reactive inflammation after tissue damage; steroid drugs are commonly used clinical immunosuppressants and anti-inflammatory drugs, such as prednisone, dexamethasone, methylprednisolone, etc. It can effectively inhibit inflammatory factors and reduce various immune cells. [0003] Existing steroidal anti-inflammatory drugs such as glucocorticoids and immunosuppressants generally have...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07J17/00A61P29/00A61P37/06
CPCA61P29/00A61P37/06C07J17/005
Inventor 程桂广邵玉亭曹建新蒋孟君姚元成赵天瑞张宏赵燕
Owner KUNMING UNIV OF SCI & TECH